U.S., March 13 -- ClinicalTrials.gov registry received information related to the study (NCT07465588) titled 'Financial Rewards for Reducing Alcohol Use in Patients With Liver Disease' on March 06.
Brief Summary: This study tests whether providing financial rewards based on a blood test result can help people with alcohol-associated liver disease (ALD) stop or reduce their drinking. The blood test is called phosphatidylethanol (PEth), which can detect alcohol use over the past three to four weeks. The financial reward program is called contingency management (CM).
The study has two parts. Part 1 involves one-time interviews and surveys with patients and healthcare providers to understand how a PEth-based CM program could best be delivered...